Clinically meaningful data establishes proof of concept for elismetrep as a promising therapeutic candidate for migraine and its progression into registrational studies anticipated to initiate ...

You're not just imagining it.

The Company's portfolio expansion initiative is being pursued independently of its existing partnership with Receptor.AI, which focuses on artificial intelligence-enabled CNS drug discovery. Together, ...

Memory tools like revision tricks and mnemonics play a major role in making this recall quick and stress-free.

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

Discover how radiofrequency ablation offers long-term pain relief for chronic sufferers, bridging the gap between temporary solutions and sustainable management.

Screens have become a permanent part of daily life. Work meetings, social media, streaming shows, and late-night scrolling ...

Cone snails deploy sophisticated venom cocktails to paralyse prey. Anthony King talks to the researchers harnessing these ...

Experiments with esports players show this non-caffeinated drink combats mental fatigue in a different way than coffee and ...

Researchers discover a neural circuit that rewards gnawing behavior with dopamine, explaining repetitive oral habits in animals and humans.

Recent research shows that GLP-1s may help reduce the need for emergency care in those with chronic migraine. This research ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...